Résultats de recherche
7 sept. 2022 · 7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board ...
View Jerry McMahon’s profile on LinkedIn, a professional community of 1 billion members. Dr. McMahon brings more than 30 years of exceptional biotechnology leadership, scientific…
- STORM Therapeutics
Jerry McMahon, PhD Chief Executive Officer & President Jerry has over 30 years of biotechnology leadership, scientific innovation, creative deal-making, and financing experience.
7 sept. 2022 · STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer. Sep 07, 2022, 03:00 ET. Industry veteran to lead STORM as it transitions into a clinical-stage company with a pipeline...
7 sept. 2022 · McMahon has held scientific, pharmaceutical and venture capital positions and has been the CEO or President of multiple biotechnology companies leading novel therapeutic programs from discovery and development to drug approvals for internal and in-licensed products.
Dr McMahon has more than 30 years’ experience in biotechnology leadership, scientific innovation, creative deal-making, and financing experience with expertise in a broad range of diseases, and a specialty in oncology therapeutics.
Jerry McMahon is President/CEO at Storm Therapeutics Ltd. See Jerry McMahon's compensation, career history, education, & memberships.
